Pfizer’s latest money grab COVID treatment has just been proven to do NOTHING for a large section of the population – but the Biden admin is still pushing us to use it.
The study found that that Paxlovid, Pfizer’s COVID medication that’s supposed to clear up symptoms fast, “provides little to no benefit” for people between the ages of 40 and 65.
The study was conducted on 109,000 patients and calls into question the United States’ decision to go with Paxlovid as the default COVID treatment.
The study concluded that the pill only benefits high risk patients above the age of 65.
Dr. David Boulware, a University of Minnesota researcher and physician said of Paxlovid, “for the vast majority of Americans who are now eligible, this really doesn’t have a lot of benefit.”
Even Pfizer itself published a study earlier in summer, saying that the pill failed to show significant benefit in healthy adults – regardless of vaccination status.
But the Biden administration doesn’t seem to care about the pills effectiveness, having handed Pfizer more than $10 billion to make the drug available at thousands of pharmacies through its test-and-treat initiative.
Members of the Biden admin have been pushing for Paxlovid to be used more commonly throughout the country and have opened thousands of sites where patients who test positive can fill a prescription. Last month, U.S. officials further expanded access by allowing pharmacists to prescribe the drug.
To learn the truth about how our government is trying to force yet another ineffective COVID treatment on us, watch the video here.